CEO, DermTech, Inc.
John Dobak, M.D. has served as Founder and CEO of several venture backed life science companies. He currently serves as the CEO of DermTech, Inc., the global leader in molecular and precision dermatology. Dr. Dobak also serves as the Chairman for 10xBio, LLC, a clinical stage pharmaceutical company developing drugs for dermatology. Dr. Dobak’s companies have developed and marketed products as diverse as cardiovascular catheters, surgical tools, and pharmaceuticals. These ventures have been financed by top tier venture capital firms (e.g. Kleiner Perkins) and notable private investors and have achieved exits through acquisition and IPO. Dr. Dobak and these companies are the recipients of several awards for entrepreneurship and innovation, including UCSD Connect’s Most Innovative New Product and MIT’s TR 100 top innovators under 40. Dr. Dobak is a member of the San Diego Chapter of the Young Presidents Organization. He received a Bachelor’s Degree from UCLA and a Medical Doctorate from UCSD.
Conference attendees will have the opportunity to hear a case study provided by peer, John Dobak, CEO of DermTech, as he shares his successes and identifies his challenges with market access and adoption. DermTech is the global leader in molecular dermatology, bringing precision medicine to the diagnosis and treatment of skin disease. Dermtech markets and […]